|
| |
CytopiaCytopia's mission is to become a leading discoverer of targeted small molecule therapeutics for diseases such as cancer, cardiovascular and immune disease, delivering drug candidates at various stages of clinical development.
The company commenced operations in 1999, based in Melbourne, Australia, and has developed world-leading expertise in kinase biology and integrated a robust structural biology program with medicinal chemistry and drug development.
| Contact Details: |
| Baker Heart Research Institute Building75 Commercial Road |
| Melbourne |
| Victoria |
| 3004 |
| Australia |
| Tel: | 61 3 9522 6900 |
| Fax: | 61 3 9510 9292 |
| Email: | cytopia@cytopia.com.au |
| WWW: | www.cytopia.com.au/
|
| |
Recent Publications by Cytopia: |  |
CYT997: a novel orally active tubulin polymerization inhibitor with potent cytotoxic and vascular disrupting activity in vitro and in vivo.
CYT997 is a wholly synthetic compound that possesses highly potent... | 6th November, 2009
| Cytopia Research Pty Ltd, Richmond, Victoria, Australia.
| Mol Cancer Ther. 2009 Nov;8(11):3036-45. Epub 2009 Nov 3.
DOI Direct Link |
Discovery of CYT997: a structurally novel orally active microtubule targeting agent.
CYT997 was discovered as a potent tubulin polymerization inhibitor... | 14th October, 2009
| Cytopia Research Pty Ltd, Richmond, VIC 3121, Australia.
| Bioorg Med Chem Lett. 2009 Aug 15;19(16):4639-42. Epub 2009 Jun 25.
DOI Direct Link |
Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs).
A series of phenylaminopyrimidines has been identified as inhibitors of... | 19th September, 2009
| Cytopia Research Pty Ltd, 576 Swan St, Richmond, VIC 3121, Australia.
| Bioorg Med Chem Lett. 2009 Oct 15;19(20):5887-92. Epub 2009 Aug 23.
DOI Direct Link |
Discovery of 2-(alpha-methylbenzylamino) pyrazines as potent Type II inhibitors of FMS.
A series of 2-(alpha-methylbenzylamino) pyrazines have shown to be potent... | 11th March, 2009
| Cytopia Research Pty Ltd, 576 Swan Street, Richmond, VIC. 3121, Australia.
| Bioorg Med Chem Lett. 2009 Feb 15;19(4):1206-9. Epub 2008 Dec 25.
DOI Direct Link |
Press Releases on Cytopia:
|
 |
| YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA |
23rd November, 2009 |
YM BioSciences Inc. |
MISSISSAUGA, ON, Nov. 23 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of
|
| YM BIOSCIENCES REPORTS CYT997 ORAL VASCULAR DISRUPTING AGENT RESULTS PRESENTED AT AACR-NCI-EORTC MEETING |
17th November, 2009 |
YM BioSciences Inc. |
MISSISSAUGA, ON, Nov. 17 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of
|
| YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS |
11th November, 2009 |
YM BioSciences Inc. |
MISSISSAUGA, ON, Nov. 11 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of
|
| New Options for Treatment of RA and Lupus are Focus of Rheumatology Thought Leader Panel |
6th November, 2009 |
MedPredict |
-- Role of other mechanisms, including CTLA4, IL-6, IL-17, JAK, Syk,
TNF/PDE4, BTK, MEK, and S1P.
Companies/Partnerships mentioned in this report include: Abbott, Alder, Amgen/Pfizer,
|
| Cytopia Letter to Progen Shareholders |
25th February, 2009 |
Cytopia Limited |
MELBOURNE, Australia, Feb. 25 /PRNewswire/ -- Cytopia Limited (ASX: CYT) has today circulated a letter and other materials to Progen Pharmaceuticals Limited (ASX: PGL) shareholders. The letter
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 252 times since April 2007, the link to the organisation's website has been followed 44 times Search for more companies in Melbourne Search for more companies in Victoria This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Cytopia |
